Community Research, Cincinnati, OH   Report issue

For profit Phase 1
Founded: Cincinnati OH United States (1995)

Organization Overview

First Clinical Trial
2010
NCT01093508
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 1 Trials (1)

apd916 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cataplexy (Phase 1)

Narcolepsy (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1